Thyrocare Technologies Ltd
NSE:THYROCARE

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
NSE:THYROCARE
Watchlist
Price: 976.55 INR 3.21% Market Closed
Market Cap: 51.7B INR
Have any thoughts about
Thyrocare Technologies Ltd?
Write Note

Intrinsic Value

The intrinsic value of one THYROCARE stock under the Base Case scenario is 587.9 INR. Compared to the current market price of 976.55 INR, Thyrocare Technologies Ltd is Overvalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

THYROCARE Intrinsic Value
587.9 INR
Overvaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Thyrocare Technologies Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for THYROCARE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about THYROCARE?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Thyrocare Technologies Ltd

Provide an overview of the primary business activities
of Thyrocare Technologies Ltd.

What unique competitive advantages
does Thyrocare Technologies Ltd hold over its rivals?

What risks and challenges
does Thyrocare Technologies Ltd face in the near future?

Summarize the latest earnings call
of Thyrocare Technologies Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Thyrocare Technologies Ltd.

Provide P/S
for Thyrocare Technologies Ltd.

Provide P/E
for Thyrocare Technologies Ltd.

Provide P/OCF
for Thyrocare Technologies Ltd.

Provide P/FCFE
for Thyrocare Technologies Ltd.

Provide P/B
for Thyrocare Technologies Ltd.

Provide EV/S
for Thyrocare Technologies Ltd.

Provide EV/GP
for Thyrocare Technologies Ltd.

Provide EV/EBITDA
for Thyrocare Technologies Ltd.

Provide EV/EBIT
for Thyrocare Technologies Ltd.

Provide EV/OCF
for Thyrocare Technologies Ltd.

Provide EV/FCFF
for Thyrocare Technologies Ltd.

Provide EV/IC
for Thyrocare Technologies Ltd.

Show me price targets
for Thyrocare Technologies Ltd made by professional analysts.

What are the Revenue projections
for Thyrocare Technologies Ltd?

How accurate were the past Revenue estimates
for Thyrocare Technologies Ltd?

What are the Net Income projections
for Thyrocare Technologies Ltd?

How accurate were the past Net Income estimates
for Thyrocare Technologies Ltd?

What are the EPS projections
for Thyrocare Technologies Ltd?

How accurate were the past EPS estimates
for Thyrocare Technologies Ltd?

What are the EBIT projections
for Thyrocare Technologies Ltd?

How accurate were the past EBIT estimates
for Thyrocare Technologies Ltd?

Compare the revenue forecasts
for Thyrocare Technologies Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Thyrocare Technologies Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Thyrocare Technologies Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Thyrocare Technologies Ltd compared to its peers.

Compare the P/E ratios
of Thyrocare Technologies Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Thyrocare Technologies Ltd with its peers.

Analyze the financial leverage
of Thyrocare Technologies Ltd compared to its main competitors.

Show all profitability ratios
for Thyrocare Technologies Ltd.

Provide ROE
for Thyrocare Technologies Ltd.

Provide ROA
for Thyrocare Technologies Ltd.

Provide ROIC
for Thyrocare Technologies Ltd.

Provide ROCE
for Thyrocare Technologies Ltd.

Provide Gross Margin
for Thyrocare Technologies Ltd.

Provide Operating Margin
for Thyrocare Technologies Ltd.

Provide Net Margin
for Thyrocare Technologies Ltd.

Provide FCF Margin
for Thyrocare Technologies Ltd.

Show all solvency ratios
for Thyrocare Technologies Ltd.

Provide D/E Ratio
for Thyrocare Technologies Ltd.

Provide D/A Ratio
for Thyrocare Technologies Ltd.

Provide Interest Coverage Ratio
for Thyrocare Technologies Ltd.

Provide Altman Z-Score Ratio
for Thyrocare Technologies Ltd.

Provide Quick Ratio
for Thyrocare Technologies Ltd.

Provide Current Ratio
for Thyrocare Technologies Ltd.

Provide Cash Ratio
for Thyrocare Technologies Ltd.

What is the historical Revenue growth
over the last 5 years for Thyrocare Technologies Ltd?

What is the historical Net Income growth
over the last 5 years for Thyrocare Technologies Ltd?

What is the current Free Cash Flow
of Thyrocare Technologies Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Thyrocare Technologies Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Thyrocare Technologies Ltd

Current Assets 2.8B
Cash & Short-Term Investments 1.5B
Receivables 434.7m
Other Current Assets 856.7m
Non-Current Assets 3.7B
Long-Term Investments 256.2m
PP&E 2B
Intangibles 1B
Other Non-Current Assets 313.2m
Current Liabilities 904.8m
Accounts Payable 401.1m
Short-Term Debt 106.9m
Other Current Liabilities 396.8m
Non-Current Liabilities 266.3m
Long-Term Debt 227.1m
Other Non-Current Liabilities 39.2m
Efficiency

Earnings Waterfall
Thyrocare Technologies Ltd

Revenue
5.9B INR
Cost of Revenue
-1.7B INR
Gross Profit
4.2B INR
Operating Expenses
-3.2B INR
Operating Income
979.8m INR
Other Expenses
-203.4m INR
Net Income
776.4m INR

Free Cash Flow Analysis
Thyrocare Technologies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

THYROCARE Profitability Score
Profitability Due Diligence

Thyrocare Technologies Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
61/100
Profitability
Score

Thyrocare Technologies Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

THYROCARE Solvency Score
Solvency Due Diligence

Thyrocare Technologies Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
90/100
Solvency
Score

Thyrocare Technologies Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

THYROCARE Price Targets Summary
Thyrocare Technologies Ltd

Wall Street analysts forecast THYROCARE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for THYROCARE is 897.6 INR with a low forecast of 888.8 INR and a high forecast of 924 INR.

Lowest
Price Target
888.8 INR
9% Downside
Average
Price Target
897.6 INR
8% Downside
Highest
Price Target
924 INR
5% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for THYROCARE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for THYROCARE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd

Country

India

Industry

Health Care

Market Cap

52.6B INR

Dividend Yield

1.84%

Description

Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 2,115 full-time employees. The company went IPO on 2016-05-09. The firm operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The firm offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The firm offers various kinds of tests, such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. The company also offers Thyroxine (T4), Triiodothyronine (T3), Thyroid-stimulating hormone and Complete Vitamin Profile tests.

Contact

MAHARASHTRA
Navi Mumbai
D-37/1, Midc, Turbhe, Opp., Sandoz
+912241252525
www.thyrocare.com

IPO

2016-05-09

Employees

2 115

Officers

MD, CEO & Chairman
Mr. Rahul Franklin Guha
Chief Financial Officer
Mr. Alok Kumar Jagnani
Chief Operating Officer
Mr. K. KallathiKumar
Company Secretary & Compliance Officer
Mr. Ramjee Dorai
Head of Strategy & Investor Relations
Mr. Pratik Hire
Chief Commercial Officer
Mr. Nitin Chugh
Show More
Vice President
Mr. Aditya Shinde
Strategy Manager
Mr. Kapil Gupta
Show Less

See Also

Discover More
What is the Intrinsic Value of one THYROCARE stock?

The intrinsic value of one THYROCARE stock under the Base Case scenario is 587.9 INR.

Is THYROCARE stock undervalued or overvalued?

Compared to the current market price of 976.55 INR, Thyrocare Technologies Ltd is Overvalued by 40%.

Back to Top